05/02/2026
A research team at AMC has successfully developed patient derived organoids for rare soft tissue sarcoma by culturing tumor cells in a gelatin based 3D environment, overcoming limitations of conventional methods. The organoids closely replicate patients’ actual tumors in genetic and pathological features, providing a strong foundation for precision medicine and personalized drug screening for this difficult to treat cancer. 🧬🧪🔬🧫🧠🎯🏥
✅ Click to read more
▲ (From left) Professor Jeong Eun Kim of the Division of Oncology at Asan Medical Center, Professor Eunyoung Tak, Dr Jiwan Choi, and researcher Kyuyoung Han of the Department of Convergence Medicine at Asan Medical Center.